Metformin is the first-line treatment for the majority of people with type 2 diabetes. Over time, you might need to add other oral meds, insulin, or other injectable drugs, like a GLP-1 receptor ...

IDF creating new Type 2 diabetes guidelines with global experts, focusing on patient-centered care and global accessibility.

addressing the critical issue of ongoing patient adherence in the management of type 2 diabetes," she continued. "In addition, the treatment is disease-modifying: it improves the patient's ...

[12] In the TODAY study, 15 clinical centers enrolled >1,200 adolescents with T2D of <2 years' duration and ... Endocrine Society Survey of Diabetes Treatment Centers Two of the authors of this ...

Groundbreaking research presented at UEG Week 2024 reveals a promising new treatment strategy for type 2 diabetes (T2D) that could significantly reduce or even eliminate the need for insulin therapy.

Welcome to this page which serves as an archive for medications that are relevant to the treatment of Type 2 Diabetes ... insight on different medication options. Click on a medication below ...

This article explores four unique subtypes of type 2 diabetes, shedding light on their causes, complications and some of ...

As part of this expanding tendency, Type 1.5 diabetes ... Constant thirst 2. Frequent urination 3. Inexplicable weight loss 4. Blurred vision and nerve tingling Treatment According to medical ...

The symptoms of the condition mean more serious ailments can arise such as serious foot problems ulcers, infections, and bone and joint pain ...

The AYUSH ministry aims to combine traditional and modern medicine in order to make treatments more effective and improve ...

Managing a chronic illness like diabetes isn’t easy, especially with the day-to-day demands of parenting. If you’re a parent living with diabetes in Singapore, balancing your health and family life ...

In 2012, NICHD selected diabetes mellitus as one of the pediatric disorders for review. Dr. William V. Tamborlane was named chair, and Dr. Linda DiMeglio, vice-chair, of the Diabetes Working Group.